GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intervacc AB (OSTO:IVACC) » Definitions » Valuation Rank

Intervacc AB (OSTO:IVACC) Valuation Rank


View and export this data going back to 2017. Start your Free Trial

What is Intervacc AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Intervacc AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of Intervacc AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Intervacc AB (OSTO:IVACC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intervacc AB (OSTO:IVACC) » Definitions » Valuation Rank
Comparable Companies
OSTO:INDEX OSTO:KDEV OSTO:MVIR OSTO:NICA OSTO:INIT OSTO:IRLAB A OSTO:ITECH OSTO:SYNACT OSTO:IMMU OSTO:SANION OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
2E9:Germany
Address
Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44
Website
https://www.intervacc.se
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.